The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis: A Randomized, Placebo-Controlled, Double-Blind, Cross-over Study.

Author(s): Diemen, H. A. M. van, Polman, C. H. , Dongen, T. M. M. M. van, Loenen, A. C. van, Nauta, J. J. P. , Taphoorn, M. J. B. , van Walbeek, H. K. , Koetsier, J. C.

Journal/Book: Ann Neurol. 1992; 32(2): 123-130.

Abstract: 70 Patienten, Cross-over, jeweils 12 Wochen Behandlung, o,5 mg/kg KG,Kurtzke-Skala Besonders temperatursensitive Patienten profitierten.

Keyword(s): MS. ks. 4-Aminopyridin. Kaliumkanalblocker

Zurück | Weiter